Skip to main content

Table 4 Prescribing practices

From: “No generics, Doctor!” The perspective of general practitioners in two French regions

  N % 95% CI
In your routine practice, what are your prescribing choices in regard to generics or originators? (Only one possible answer)
 It depends on the situation 233 73.7 70.7–76.6
 I prescribe only generics or by INN a 50 15.8 13.5–18.4
 I prescribe only originators 33 10.4 8.4–12.9
You answered, “It depends on the situation”. Can you expand on this response? (Several possible answers)
 I prescribe an originator if the patient asks for it, even without a reason 110 34.8 31.4–38.3
 A priori, I systematically prescribe an originator for certain drugs 89 28.2 25.0–31.5
 A priori, I systematically prescribe an originator for fragile patients 61 19.3 16.6–22.3
 I prescribe an originator on a case-by-case basis if the patient reports adverse effects 50 15.8 13.4–18.6
 I mainly prescribe by INN a 36 11.4 9.3–13.9
 A priori, I systematically prescribe an originator for certain diseases 31 9.8 7.9–12.2
 I prescribe an originator on a case-by-case basis if I observe adverse effects 22 7.0 5.3–9.0
 I prescribe by INN a with the name of the originator in brackets 22 7.0 5.3–9.0
 I prescribe by INN a or a generic as the initial prescription 10 3.2 2.1–4.7
 I prescribe an originator on a case-by-case basis if the patient says that the generic was not effective 8 2.5 1.6–4.0
 I prescribe an originator on a case-by-case basis if I see that the generic was not effective 7 2.2 1.4–3.6
  1. aINN, International Non-proprietary Name
\